NanoSyrinx
PrivateLast Round
Series A
Sep 10, 2024
Total Funding Raised
$22.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NanoSyrinx operates in Healthcare & Life Sciences and is based in Coventry. Its latest recorded funding round was a Series A round in September 2024.
NanoSyrinx is a biotechnology company that develops a synthetic biology platform for the targeted intracellular delivery of therapeutic proteins and peptides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoSyrinx Comparables
Compare NanoSyrinx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 83% | |
| Sapreme Technologies BV | 82% | |
| Edity Therapeutics | 82% |
For institutional investors. Book with your work email.
NanoSyrinx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 10, 2024 | ||||
| Seed | Jul 14, 2021 | ||||
| Pre Seed | Sep 30, 2020 | ||||
| Grant | Sep 30, 2020 | ||||
| Grant | Jun 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoSyrinx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Grant |
| BGF | Series A |
| Pioneer Group | Seed, Pre Seed |
| M Ventures | Seed, Pre Seed, Series A |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| Innovate UK | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 39% MoM, reaching 2.1K.
- Jun 19, 2026
Monthly visitors grew 202% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
NanoSyrinx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoSyrinx's valuation, stock price, and market status.
Is NanoSyrinx a public or private company?
NanoSyrinx is a private company.
What is the current stock price of NanoSyrinx?
NanoSyrinx is a private company, so its shares have no public market price. Caplight tracks NanoSyrinx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoSyrinx worth (valuation)?
Valuation information for NanoSyrinx is not publicly available.
Can I buy NanoSyrinx stock?
NanoSyrinx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoSyrinx's last funding round?
NanoSyrinx's most recent funding round was Series A on September 10, 2024.
Who are the main investors in NanoSyrinx?
Key investors in NanoSyrinx include BGF, M Ventures, Octopus Ventures.
Will NanoSyrinx IPO soon?
No public IPO plans have been announced for NanoSyrinx.
How can I track NanoSyrinx secondary market activity?
Caplight tracks bids, offers, and trades in NanoSyrinx's shares on secondary markets.